胃癌;法舒地尔;迁移;侵袭;基质金属蛋白酶;血管内皮生长因子

," /> 胃癌;法舒地尔;迁移;侵袭;基质金属蛋白酶;血管内皮生长因子

,"/> Gastric cancerFasudilMigrationInvasionMatrix metalloproteinases MMP);Vascular endothelial growth factor VEGF,"/>  <span style="font-family:宋体;">法舒地尔对胃癌</span><span>MGC</span><span style="font-family:宋体;">-</span><span>803</span><span style="font-family:宋体;">细胞增殖、侵袭和迁移的影响</span>

临床肿瘤学杂志 ›› 2018, Vol. 23 ›› Issue (10): 875-880.

• 论著 • 上一篇    下一篇

 法舒地尔对胃癌MGC-803细胞增殖、侵袭和迁移的影响

  

  1. 1  450000 河南郑州 郑州市第七人民医院药学部 450000  郑州市第七人民医院消化内科

     

  • 收稿日期:2018-02-23 修回日期:2018-07-07 出版日期:2018-10-31 发布日期:2019-03-20
  • 基金资助:
    河南省科技攻关资助项目(142102310212)

 Effect of Fasudil on proliferation, invasion and metastasis of gastric cancer MGC-803 cells

  1. Department of Faculty of Pharmaceutical Sciences the Seventh Peoples Hospital of Zhengzhou Zhengzhou 450000
  • Received:2018-02-23 Revised:2018-07-07 Online:2018-10-31 Published:2019-03-20

摘要:  目的  探讨法舒地尔对胃癌MGC-803细胞增殖、侵袭和迁移的影响及可能机制。方法  采用不同浓度的法舒地尔处理胃癌MGC-803细胞,检测细胞数目;选择无显著细胞毒性的3组浓度(102550 μmolL)法舒地尔进行后续实验,将经药物处理的胃癌MGC-803细胞作为处理组,而未经药物处理的胃癌MGC-803 细胞作为对照组;细胞培养024487296 h后,CCK-8法检测细胞增殖倍数;划痕实验检测细胞迁移能力;Transwell法检测细胞侵袭能力;Western blotting检测细胞中血管内皮细胞生长因子(VEGF)、基质金属蛋白酶9MMP-9)、基质金属蛋白酶14MMP-14)和上皮间质转化(EMT)的标志蛋白波形蛋白(Vimentin)和上皮型钙黏蛋白(E-cadherin)的表达水平。结果  CCK-8法检测结果显示,法舒地尔以剂量依赖性的方式抑制胃癌MGC-803细胞的生长,法舒地尔浓度越高,处理组的细胞数量越少,增殖倍数明显降低(P0.01);划痕实验结果表明,处理组伤痕愈合率明显较对照组降低,且法舒地尔浓度越高,处理组伤痕愈合率越低(P0.01);Transwell结果显示,与对照组比较,处理组侵袭的细胞数目明显减少(P0.01);与对照组比较,法舒地尔明显下调VEGFMMP-9MMP-14Vimentin蛋白的表达水平,而上调E-cadherin蛋白的表达水平。结论  法舒地尔可抑制胃癌MGC-803细胞的的增殖、迁移和侵袭能力,降低MMP-9MMP-14VEGF表达水平,为胃癌的治疗研究提供新思路和理论基础。

关键词:  , 胃癌;法舒地尔;迁移;侵袭;基质金属蛋白酶;血管内皮生长因子

">胃癌;法舒地尔;迁移;侵袭;基质金属蛋白酶;血管内皮生长因子

')">">

Abstract:  

Objective  To investigate the effect of Fasudil on the pfoliferation invasion and migration of gastric cancer MGC-803 cells and their probable mechanisms. Methods  MGC-803 cells were treated with different concentration of Fasudil and cell number was counted. And the subsequent experiments were conducted in 3 groups respectively contained 10 25 50 μmolL of Fasudil, the MGC-803 cells treated with Fasudil were taken as the treatment group while those not treated with Fasudil were taken as the control group. The cells were cultured for 4 days0 24 48 72 96 h), and the cell growth folds were detected by CCK-8.The ability of cell migration was detected by wound-healing assay. The ability of cell invasion was detected by Transwell. The protein expression levels of vascular endothelial growth factor VEGF), matrix metalloproteinases 9MMP-9), matrix metalloproteinases14 MMP-14 and epithelial mesenchymal transformation EMT markers Vimentin and E-cadherin were detected by Western blotting. Results  The toxicity test showed that Fasudil inhibited the cell growth of MGC-803 cells in a dose-dependent manner and the cell growth folds were reduced in the treatment group. There was an obvious decrease in the growth folds compared to the control group P0.01. The results of wound healing assay showed that the wound closure rate in the treatment group was lower than that of the control group and in a dose-dependent mannerP0.01. Transwell results showed that the number of invasive cells in the treatment group was decreased significantly compared with the control group P0.01. Besides Fasudil significantly decreased the expression levels of VEGF MMP-9 MMP-14 and Vimentin and up-regulated the expression levels of E-cadherin. Conclusion  Fasudil may inhibit cell proliferation migration and invasion of MGC-803 cells reduce the activity of MMP-9 MMP-14 and VEGF which will provide new sight and theoretical basis for the treatment of gastric cancer.

Key words: font-family:宋体, Gastric cancer">Gastric cancerfont-family:宋体, FasudilMigrationInvasionMatrix metalloproteinases MMP);Vascular endothelial growth factor VEGF)')">">;FasudilMigrationInvasionMatrix metalloproteinases MMP);Vascular endothelial growth factor VEGF

中图分类号: 

  • R735.2
[1] 何灏澜, 李 倩, 姜 晗, 王 晓, 陆 明.

光辉霉素对胃癌细胞周期、凋亡的影响及可能机制 [J]. 临床肿瘤学杂志, 2019, 24(2): 133-136.

[2] 牛 虹, 田同德, 唐静雯, 岳光星, 李华华, 范伊晓, 周浩本.

微小RNA-148a-3p靶向调控MAP3K9表达及对胃癌细胞增殖和凋亡的影响 [J]. 临床肿瘤学杂志, 2019, 24(2): 108-112.

[3] 何家杰, 李 敏, 唐国富, 李厚泽, 綦晓龙.

异隐丹参酮对胃癌细胞增殖、周期和凋亡的影响 [J]. 临床肿瘤学杂志, 2019, 24(2): 129-132.

[4] 顾永娟, 陈亚楠. 胃癌PI3K和Akt及Survivin表达与临床病理特征及预后的相关性研究[J]. 临床肿瘤学杂志, 2018, 23(5): 413-418.
[5] 俞进友, 仇建玲, 朱正峰, 田翠芳. 胃癌组织中miR-98和miR-183表达及临床意义[J]. 临床肿瘤学杂志, 2018, 23(5): 408-412.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!